Innovative Nasal Spray Targets Age-Related Cognitive Decline
A newly developed nasal spray aims to combat cognitive impairments that often accompany aging. Researchers at Texas A&M University have created a treatment using extracellular vesicles containing microRNA, which has shown promising results in restoring memory and reducing inflammation in the central nervous system. The study, led by Dr. Ashok Shetty—associate director of the Institute for Regenerative Medicine—was published in the Journal of Extracellular Vesicles.
How the Therapy Works
Delivered intranasally, the therapy bypasses the blood-brain barrier—a critical advantage for delivering active ingredients directly to the brain. After just two doses, the treatment led to:
- restoration of lost memory functions;
- reduction of chronic inflammation;
- improvement in overall brain cell function.
The spray’s active compound suppresses inflammatory pathways, particularly the NLRP3 inflammasome, and restores mitochondrial activity, contributing to better patient outcomes.
Behavioral tests conducted during the study showed improvements in memory and object recognition tasks. These benefits persisted for several months after the two-dose regimen. Notably, the results were consistent across both sexes, suggesting the approach is broadly applicable. The research team received support from the National Institute on Aging (NIA) and has filed a U.S. patent application. Senior scientists involved in the project include Dr. Madhu Lilaavati Narayana and Dr. Mahidhara Kodali.
This nasal spray represents a significant step forward in treating cognitive decline in older adults. With the World Health Organization reporting a rising number of elderly individuals affected by various forms of dementia, the need for effective treatments is urgent. The study’s positive outcomes could pave the way for clinical trials and eventual integration into medical practice, ultimately improving quality of life for the aging population.
In light of these promising findings, it's essential to explore other innovative approaches to combat neurodegenerative conditions. For instance, recent research has demonstrated how scientists have effectively halted neuroinflammation associated with Alzheimer's disease, which could complement therapies like the newly developed nasal spray. To learn more about this breakthrough, visit this detailed report.